Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone

Authors

Gene L. Colice, George Washington UniversityFollow
Richard J. Martin, National Jewish Health, Denver, CO
Elliot Israel, Brigham and Women's Hospital, Boston, MA
Nicolas Roche, University of Paris Descartes, Paris, France
Neil Barnes, Barts Health NHS Trust, London, United Kingdom
Anne Burden, Research in Real Life, Cambridge, United Kingdom
Peter Polos, i3 Global, Basking Ridge, NJ
Paul Dorinsky, Teva Global Respiratory Research and Development, Horsham, PA
Elizabeth V. Hillyer, Research in Real Life, Cambridge, United Kingdom
Amanda J. Lee, University of Aberdeen, Aberdeen, UK
Alison Chisholm, Research in Real Life, Cambridge, United Kingdom
Julie von Ziegenweidt, Research in Real Life, Cambridge, United Kingdom
Francesca Barion, Research in Real Life, Cambridge, United Kingdom
David Price, Research in Real Life, Cambridge, United Kingdom

Document Type

Journal Article

Publication Date

2013

Journal

Journal of Allergy and Clinical Immunology

Keywords

Androstadienes--administration & dosage; Anti-Asthmatic Agents--administration & dosage; Asthma--drug therapy; Beclomethasone--administration & dosage; Bronchodilator Agents--administration & dosage; Health Care Costs

APA Citation

[Epub ahead of print]

Peer Reviewed

1